Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
Schulte-Frohlinde E, Wagenpfeil S, Willis J, Lersch C, Eckel F, Schmid R, Schusdziarra V. J Gastroenterol Hepatol. 2007 Aug;22(8):1241-8.
L-arginine and cardiovascular system.
Cylwik D, Mogielnicki A, Buczko W. Pharmacol Rep. Jan-Feb 2005;57(1):14-22.
Plasma concentrations of excitatory amino acids serine, glycine, taurine and histidine in major depression.
Altamura C, Maes M, Dai J, Meltzer HY. Eur Neuropsychopharmacol. 1995;5 Suppl:71-75.
Tryptophan depletion, serotonin, and depression: where do we stand?
Neumeister A. Psychopharmacol Bull. 2003;37(4):99-115.
Pharmacogenetics and individual variation in the range of amino acid adequacy: the biological aspects.
Caldwell J. J Nutr. Jun 2004;134(6 Suppl):1600S-1604S; discussion 1630S-1632S, 1667S-1672S.
Metabolomics and its potential for assessment of adequacy and safety of amino acid intake.
Noguchi Y, Sakai R, Kimura T. J Nutr. Jun 2003;133(6 Suppl 1):2097S-2100S.
Effect of cortisol on energy expenditure and amino acid metabolism in humans.
Brillon DJ, Zheng B, Campbell RG, Matthews DE. Am J Physiol. 1995;268(3 Pt 1):E501-513.
Protein requirements and supplementation in strength sports.
Phillips SM. Nutrition. Jul-Aug 2004;20(7-8):689-695.
Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and
arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.
Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpe S. Acta Psychiatr Scand. Apr 1998;97(4):302-308.
Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease.
Ravaglia G, Forti P, Maioli F, et al. Am J Clin Nutr. Aug 2004;80(2):483-488.
Contribution of dietary protein and inorganic sulfur to urinary sulfate: toward a biomarker of inorganic sulfur intake.
Magee EA, Curno R, Edmond LM, Cummings JH. Am J Clin Nutr. Jul 2004;80(1):137-142.
Macronutrient intakes as determinants of dietary protein and amino acid adequacy.
Millward DJ. J Nutr. Jun 2004;134(6 Suppl):1588S-1596S.
Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass
in healthy individuals: the effect of N- acetyl-cysteine.
Kinscherf R, Hack V, Fischbach T, et al. J Mol Med. 1996;74(7):393-400.
Co-existence of GABA and Glu in the hippocampal granule cells: implications for epilepsy.
Gutierrez R, Heinemann U. Curr Top Med Chem. 2006;6(10):975-978.
Response of alanine metabolism in humans to manipulation of dietary protein and energy intakes.
Yang RD, Matthews DE, Bier DM, Wen ZM, Young VR. Am J Physiol. Jan 1986;250(1 Pt 1):E39-46.
Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro:
implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder.
Modica-Napolitano JS, Renshaw PF. Biol Psychiatry. Feb 1 2004;55(3):273-277.
Plasma proline and leucine kinetics: response to 4 wk with proline-free diets in young adults.
Hiramatsu T, Cortiella J, Marchini JS, Chapman TE, Young VR. Am J Clin Nutr. 1994;60(2):207-215.
Gender-related differences in carnosine, anserine and lysine content of murine skeletal muscle.
Penafiel R, Ruzafa C, Monserrat F, Cremades A. Amino Acids. Feb 2004;26(1):53-58.
Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
Elia M, Carter A, Bacon S, Winearls CG, Smith R. Br Med J (Clin Res Ed). 1981;282(6261):351-354.
